Ultra-Strength Pain Relief Analgesic CAMPHOR (SYNTHETIC) and MENTHOL, UNSPECIFIED FORM 110 mg/g; 110 mg/g Ointment — NDC 82442-0311-01 package photo

Ultra-Strength Pain Relief Analgesic CAMPHOR (SYNTHETIC) and MENTHOL, UNSPECIFIED FORM 110 mg/g; 110 mg/g Ointment

by TARGET CORPORATION · 1 JAR in 1 CARTON (82442-311-01) / 18 g in 1 JAR
NDC 82442-0311-01
🏷️ FDA NDC (as labeled) 82442-311-01 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 82442-311-01
Product NDC 82442-311
11-digit billing NDC 82442031101
RxCUI 1089847
UNII 5TJD82A1ET, L7T10EIP3A
Application # M017
SPL Set ID 159c5a84-bf68-41dd-a2d3-bc2402037244
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-10-14
Route TOPICAL
Dosage form OINTMENT
Substance CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM
Why two NDCs? The FDA registers this code as 82442-311-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 82442-0311-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerTARGET CORPORATION
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code82442
First marketedOct 2024
Product typeHuman Otc Drug
Portfolio408 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an over-the-counter topical ointment marketed under FDA's OTC monograph rules for pain relief products. It contains camphor (synthetic) and menthol, two ingredients commonly used in topical preparations because they are thought to produce warming or cooling sensations on the skin. These ingredients are typically included in products meant to be rubbed onto the skin over sore muscles or joints as part of a pain relief approach. The ointment form allows the active ingredients to be applied directly to affected areas.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 4U4V2F2E4Y
    A fragrant oil derived from cinnamon leaves, used as a flavoring agent to improve taste and add aroma to medications.
  • UNII 578389D6D0
    Clove oil is an essential oil derived from clove plant buds. It's used in medicines as a flavoring agent and for its mild preservative properties to help maintain product stability.
  • UNII B68LJT9544
    A fatty acid derivative used as a preservative and antimicrobial agent in topical medicines. It helps prevent bacterial and fungal growth to maintain product stability and safety.
  • UNII TM2TZD4G4A
    A plant-derived oily substance used as an emulsifier and solubilizer in medicines. It helps blend water and oil-based ingredients together and improves how the body absorbs certain active drugs.
  • UNII 48H19MS04L
    A natural oil derived from the fruit of the Mauritia flexuosa palm tree. It serves as an emollient and skin-conditioning agent in topical formulations, helping soften and smooth the product's texture.
  • UNII AV092KU4JH
    A natural oil extracted from peppermint plants. It's used as a flavoring agent to mask bitter tastes and add a refreshing mint flavor to medicines, making them easier to take.
  • UNII 4T6H12BN9U
    Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.

7 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesCinnamomum Cassia Leaf Oil, Eugenia Caryophyllus (Clove) Bud Oil, Glyceryl Caprylate, Glyceryl Undecylenate, Mauritia Flexuosa Fruit Oil, Melaleuca Leucadendron Cajaput Leaf Extract, Mentha Piperita (Peppermint) Oil, Petrolatum

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
CVS Muscle Balm 110 mg/g; 110 mg/g 51316-0240-01 CVS 1 jar FDA listed
CVS Muscle Balm and Roll-On 51316-0241-01 CVS 1 kit FDA listed
Tiger Balm Ultra Strength 110 mg/g; 110 mg/g 66761-0315-02 Haw 2 g FDA listed
Muscle Balm 110 mg/g; 110 mg/g 66902-0142-63 Natural 18 g FDA listed
GuruNanda Pain Relief 110 mg/g; 110 mg/g 70708-0937-13 GURUNANDA, 1 jar FDA listed
Ultra Strength Pain Relief Balm 110 mg/g; 110 mg/g 73492-0711-18 ALAINA 1 bottle FDA listed
Pain Relief Balm 110 mg/g; 110 mg/g 73492-0718-15 ALAINA 1 jar FDA listed
Equate Pain Relief Balm 110 mg/g; 110 mg/g 79903-0105-18 WALMART, 1 bottle FDA listed
Ultra-Strength Pain Relief Analgesic 110 mg/g; 110 mg/gthis 82442-0311-01 TARGET 1 jar FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Oct 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for CAMPHOR (SYNTHETIC) and MENTHOL, UNSPECIFIED FORM — the ingredient across all brands.

Top reported reactions

Back Pain9
Nausea9
Pain9
Fatigue6
Dyspnoea5
Peripheral Swelling5
Tremor5

Age at onset

Adult1
Elderly4

Reporter sex

80 reports
Male · 22%
Female · 77%
Unknown · 1%

Serious outcomes

Hospitalization15
Disabling7
Life-threatening4
Death1
Reports over time (by year) — tap or hover for the count & year
2024 2025 2026 12 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
82442-0311-01 You're viewing this 1 JAR in 1 CARTON (82442-311-01) / 18 g in 1 JAR 2024-10-14 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 82442-311-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 82442-0311-01, written without dashes as 82442031101. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 82442-0311-01, the first segment (82442) is the labeler code FDA assigned to TARGET CORPORATION; the middle segment (0311) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by TARGET CORPORATION. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
TARGET CORPORATION is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 22 words

Uses For the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, and sprains.

⏱️ Dosage and Administration 35 words

Directions Adults and children 12 years of age and older: Apply to affected area not more than 3 to 4 times daily. Children under 12 years of age : do not use, consult a doctor.

⚠️ Warnings 131 words

Warnings For external use only When using this product avoid contact with the eyes and the mucous membranes use only as directed do not apply to wounds or damaged skin do not bandage tightly do not use with heating pads or heating devices do not use 1 hour before bathing or within 30 minutes after bathing wash hands after use with cool water. Stop use and ask a doctor if condition worsens severe skin irritation occurs symptoms persist for more than 7 days or clear up and occur again within a few days. If you are pregnant, or breast-feeding or if you have sensitive skin, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📦 Storage and Handling 13 words

Other information store in a cool dry place with the lid closed tightly.

🧪 Active Ingredient 11 words

Active ingredient Purpose Camphor 11% Topical analgesic Menthol 11% Topical analgesic

🧪 Inactive Ingredients 29 words

Inactive ingredients Cinnamomum Cassia Leaf Oil, Eugenia Caryophyllus (Clove) Bud Oil, Glyceryl Caprylate, Glyceryl Undecylenate, Mauritia Flexuosa Fruit Oil, Melaleuca Leucadendron Cajaput Leaf Extract, Mentha Piperita (Peppermint) Oil, Petrolatum

🎯 Purpose 11 words

Active ingredient Purpose Camphor 11% Topical analgesic Menthol 11% Topical analgesic

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.